https://orcid.org/0000-0002-6042-656X
References
- Fekete GL, Fekete L, Neagu N, Bacârea V, Drăgănescu M, Brihan I. Keratosis pilaris atrophicans faciei: an observational, descriptive, retrospective clinical study. Exp Ther Med. 2021;22(5):1331. doi:10.3892/etm.2021.10766
- Callaway SR, Lesher JL Jr. Keratosis pilaris atrophicans: case series and review. Pediatr Dermatol. 2004;21(1):14–17. doi:10.1111/j.0736-8046.2004.21103.x
- Liakou AI, Esteves de Carvalho AV, Nazarenko LP. Trias of keratosis pilaris, ulerythema ophryogenes and 18p monosomy: zouboulis syndrome. J Dermatol. 2014;41(5):371–376. doi:10.1111/1346-8138.12442
- Algharbi N, Jazzar Y, Shadid A, Almesfer A. Ulerythema ophryogenes in a Saudi male: a case report. Cureus. 2022;14(7):e26593. doi:10.7759/cureus.26593
- Pan PY, Wei KC, Wu JC, Lin JH. A novel fractional solid-state 585 nm laser on facial verruca plana: a report of three cases. J Cosmet Dermatol. 2022;21(5):1986–1988. doi:10.1111/jocd.14857
- Kechichian E, Jabbour S, El Hachem L, Tomb R, Helou J. Light and laser treatments for keratosis pilaris: a systematic review. Dermatol Surg. 2020;46(11):1397–1402. doi:10.1097/DSS.0000000000002441
- Clark SM, Mills CM, Lanigan SW. Treatment of keratosis pilaris atrophicans with the pulsed tunable dye laser. J Cutan Laser Ther. 2000;2:151–156. doi:10.1080/14628830050516416
- Wang JF, Orlow SJ. Keratosis pilaris and its subtypes: associations, new molecular and pharmacologic etiologies, and therapeutic options. Am J Clin Dermatol. 2018;19(5):733–757. doi:10.1007/s40257-018-0368-3
- Gonzalez JA, Boixeda P, Truchuelo Diez MT, Fleta Asın B. Keratosis pilaris rubra and keratosis pilaris atrophicans faciei treated with pulsed dye laser: report of 10 cases. J Eur Acad Dermatol Venereol. 2011;25(6):710–714. doi:10.1111/j.1468-3083.2010.03772.x